Ultragenyx Pharmaceutical: Canaccord Genuity cuts target price to $34 from $39
RARE•Canaccord Genuity cut its target price for Ultragenyx Pharmaceutical to $34 from $39.
Related News
Shopify Inc.: MoffettNathanson cuts target price to $170 from $175
SHOP•
Piper Sandler cuts Shopify target price to $172 from $180
SHOP•
Amneal Pharma: Leerink Partners raises target price to $25 from $23
AMRX•
NBCUniversal, MIT Investment join Indian microdrama firm's $80 million funding round
CMCSA•
Fiserv: JPMorgan raises target price to $65 from $60
FISV•